the randomized trial of aspirin and sulfinpyrazone in threatened stroke compared aspirin ( 325 mg four times daily ) , sulfinpyrazone ( 200 mg four times daily ) and aspirin plus sulfinpyrazone with placebo in patients with transient cerebral ischemia .
C0038454
stroke
C0007787
transient cerebral ischemia